Find therapies in clinical trials near you – page 437

Study on the Safety and Tumor-Fighting Effects of OMO-103 for Patients with Advanced Osteosarcoma

Study on the Safety and Tumor-Fighting Effects of OMO-103 for Patients with Advanced Osteosarcoma

Detecting Heart Inflammation in Cardiac Sarcoidosis Patients Using 68Ga-NOTA-Anti-MMR-VHH2 PET-CT Imaging

Detecting Heart Inflammation in Cardiac Sarcoidosis Patients Using 68Ga-NOTA-Anti-MMR-VHH2 PET-CT Imaging

Study of tezepelumab in patients with progressive pulmonary fibrosis and increased eosinophil levels in blood

Study of tezepelumab in patients with progressive pulmonary fibrosis and increased eosinophil levels in blood

Study on Improving Sexual Function in Men and Women After Rectal Cancer Treatment Using Tadalafil

Study on the Effects of Escitalopram, Paroxetine, and Naltrexone for Patients with Compulsive Sexual Behavior Disorder

Study on the Effects of Escitalopram, Paroxetine, and Naltrexone for Patients with Compulsive Sexual Behavior Disorder

Study on the Effects of Rapcabtagene Autoleucel in Patients with Systemic Lupus Erythematosus and Active, Refractory Lupus Nephritis

Study on the Effects of Rapcabtagene Autoleucel in Patients with Systemic Lupus Erythematosus and Active, Refractory Lupus Nephritis

Study on Teprenone for Preventing Atrial Fibrillation After Heart Surgery in Patients

Study on Teprenone for Preventing Atrial Fibrillation After Heart Surgery in Patients

Study on Acetylsalicylic Acid for Colorectal Cancer Patients with PI3K Pathway Mutations

Study on Acetylsalicylic Acid for Colorectal Cancer Patients with PI3K Pathway Mutations

Study of KYV-101 Therapy for Patients with Refractory Primary and Secondary Progressive Multiple Sclerosis

Study of KYV-101 Therapy for Patients with Refractory Primary and Secondary Progressive Multiple Sclerosis

Study comparing rapcabtagene autoleucel and rituximab in patients with severe refractory diffuse cutaneous systemic sclerosis

Study comparing rapcabtagene autoleucel and rituximab in patients with severe refractory diffuse cutaneous systemic sclerosis

Study Comparing Two Cisplatin Dosing Schedules with Radiation for Patients with Advanced Head and Neck Cancer

Study Comparing Two Cisplatin Dosing Schedules with Radiation for Patients with Advanced Head and Neck Cancer

Study of Spartalizumab and Pazopanib for Patients with Refractory or Recurrent Solid Tumors

Study of Spartalizumab and Pazopanib for Patients with Refractory or Recurrent Solid Tumors